Commercial Funding Opportunity

Through Fast Forward, we are making high-impact early-stage investments to accelerate commercial R&D for new therapies for people living with MS.

Therapeutic Development Opportunities for Neuroprotection and Neuroregeneration in Multiple Sclerosis

Details on the current funding opportunity are available to download below. To submit a proposal for Fast Forward support, applicants must first register with our online portal (https://nmss.fluxx.io) and complete a brief pre-application. Staff will review the pre-application to determine whether the proposed research plan is appropriate and relevant to the objectives of the Request for Proposals (RFP).

Important dates: 
Pre-applications will be accepted beginning October 24^th, 2018
Final date for acceptance of pre-applications: December 5^th, 2018
Final date for receipt of completed full applications: December 19^th, 2018 

• Download information on the Therapeutic Development Opportunities for Neuroprotection and Neuroregeneration in Multiple Sclerosis RFP 

• Download instructions for online submission of Fast Forward applications (.pdf)   
• Download the proposal guidelines for the current commercial funding opportunity (.pdf)

 
For more information, please contact:

Mark Allegretta PhD    
Vice President, Research
mark.allegretta@nmss.org
212-476-0459
        
Maya Merrell
Director, Business and Partnership Development
maya.merrell@nmss.org
212-476-0443
        
Walter Kostich PhD    
Director, Commercial Research
walter.kostich@nmss.org
212-476-0428